A plasma cell neoplasm associated with osteosclerotic and fibrotic changes in the bone trabeculae. Often, the lymph nodes show changes resembling the plasma cell variant of Castleman disease. It is of...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Callisto Pharmaceuticals, Inc.
Other
Celgene Corporation
Other
Dexcel Pharma Technologies Ltd
Other
Janssen Research & Development, LLC
Other
Juno Therapeutics, Inc.
Other
Oncopeptides AB
Other
Takeda Pharmaceuticals U.S.A., Inc.
Other
Trillium Therapeutics, Inc.
Other
XTL Biopharmaceuticals, Ltd
Other